Welcome to our dedicated page for AEHR TEST SYSTEMS SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
Howard Theo Slayen filed a Rule 144 notice for a potential sale of up to 5,700 shares of Charles Schwab Corp. common stock. The filing lists an aggregate market value of $753,910.50 for these shares and notes 32,620,450 shares outstanding, with an approximate sale date of August 14, 2026. It also discloses prior open market purchase dates that correspond to the shares being registered for resale and reports a separate sale of 20,000 shares during the past three months for $2,165,874.71.
Aehr Test Systems insider Rhea Posedel filed a notice to sell common stock under a Form 144. The planned sale covers 5,973 common shares through broker Oppenheimer & Co. Inc., with an aggregate market value of $836,220.00, expected on or about August 14, 2026 on Nasdaq.
The shares were originally acquired on April 20, 2021 as compensation from the issuer. Over the past three months, a separate sale of 8,413 common shares for an aggregate $1,093,690.00 was reported.
AEHR TEST SYSTEMS executive Alberto Salamone reported two open-market sales of company common stock on 2026-08-13, totaling 9,672 shares. Shares were sold at per-share prices of $128.00 and $127.5014. A portion of the reported holdings includes shares subject to unvested restricted stock units.
AEHR filed a Form 144 indicating an intention to sell common stock through Fidelity Brokerage Services LLC. The filing lists 2,000 shares of common stock, with an aggregate value of $273,000.00, to be sold on or after 08/14/2026 on NASDAQ. It also details future common stock from restricted stock vesting granted as compensation, including 47, 248, 795, 478 and 432 shares vesting on specific dates in 2024 and 2025.
Aehr Test Systems President and CEO Gayn Erickson reported two open-market sales of company common stock on August 12, 2026, totaling 40,000 shares held indirectly through a trust. The filing also reports 197,521 shares held directly after the transactions, including shares subject to unvested restricted stock units and unvested restricted shares.
Aehr Test Systems director Rhea J. Posedel reported selling 8,413 shares of common stock on August 12, 2026 at $130 per share through an entity classified as a trust. Following this sale, indirect holdings total 387,962 shares and direct holdings total 47,156 shares, which include shares subject to unvested restricted stock units.
Aehr Test Systems director Geoffrey Scott reported two indirect transactions in Common Stock on 2026-08-12. An entity associated with him made a bona fide gift of 6,731 shares held by a trust to the Scott Family Gift Fund, leaving 23,955 indirect trust shares. His spouse sold 20,000 indirect shares at $131.506 per share, leaving 10,000 indirect shares. Separately, he holds 51,648 shares directly, including shares subject to unvested restricted stock units. The transactions were not reported under a Rule 10b5-1 trading plan.
AEHR TEST SYSTEMS Chief Operating Officer Adil Engineer reported a same-day option exercise and sale sequence. He exercised options to acquire 15,000 shares of common stock at an exercise price of $9.45 per share, then sold 7,500 shares at $130.9549 and another 7,500 shares at $131.0950 per share. Following the derivative exercises, he reported remaining direct option holdings of 31,330 and 28,088 options in the respective grants. One reported amount of common stock includes shares subject to unvested restricted stock units.
Aehr Test Systems director Laura Oliphant reported a sale of 1,717 shares of Common Stock on 2026-08-12 in an open market or private transaction at $133.00 per share. Following this transaction, she reported holding 16,100 shares, which the company notes include shares subject to unvested restricted stock units.
A holder of AEHR common stock filed a notice of intent to sell shares. The planned transaction covers 9,672 shares of common stock to be sold through Fidelity Brokerage Services LLC on August 13, 2026 on NASDAQ, with an aggregate market value of $1,235,287.65. The shares to be sold were originally acquired in several transactions, including 7,200 shares obtained in a merger for cash on August 1, 2024, and restricted stock that vested as compensation in lots of 2,091 shares on July 2, 2025 and 381 shares on August 1, 2025.